deltatrials
Completed OBSERVATIONAL NCT05090098

Breast Cancer and Kinesiophobia and Physical Activity

Comparison of the Effects of Fear of Movement and Physical Activity Barriers on Physical Activity, Quality of Life and Psychological State of Women Who Have Had or Are Having Breast Cancer With Healthy People - Case Control Study

Sponsor: Acibadem University

Interventions None intervention
Updated 7 times since 2021 Last updated: May 30, 2022 Started: Aug 1, 2021 Primary completion: Nov 15, 2021 Completion: May 15, 2022
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Breast Cancer and Kinesiophobia, this trial is completed. The trial is conducted by Acibadem University and has accumulated 7 data snapshots since 2021. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

~Nov 2021 – ~Jan 2022 · 2 months · monthly snapshot~Jan 2022 – ~Apr 2022 · 3 months · monthly snapshot~Apr 2022 – ~Jul 2022 · 3 months · monthly snapshot~Jul 2022 – ~Jul 2024 · 24 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshotCompleted~Sep 2025 – present · 10 months · monthly snapshotCompleted

Change History

7 versions recorded
  1. Sep 2025 — Present [monthly]

    Completed

  2. Sep 2024 — Sep 2025 [monthly]

    Completed

  3. Jul 2024 — Sep 2024 [monthly]

    Completed

  4. Jul 2022 — Jul 2024 [monthly]

    Completed

    Status: RecruitingCompleted

  5. Apr 2022 — Jul 2022 [monthly]

    Recruiting

Show 2 earlier versions
  1. Jan 2022 — Apr 2022 [monthly]

    Recruiting

  2. Nov 2021 — Jan 2022 [monthly]

    Recruiting

    First recorded

Aug 2021

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Acibadem University
Data source: Acibadem University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations